Filing metadata

Accession number
0001104659-21-046193
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Apr 02, 2021
Reporting period
Mar 31, 2021
Description
Insider transaction

Explore SEC Filings Hub